Ignite Creation Date:
2025-12-24 @ 5:21 PM
Ignite Modification Date:
2026-02-18 @ 11:33 AM
Study NCT ID:
NCT03391050
Status:
TERMINATED
Last Update Posted:
2019-07-31
First Post:
2017-12-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of APR-246 in Combination With Dabrafenib in Resistant Patients With BRAF V600 Mutant Melanoma
Sponsor:
Aprea Therapeutics
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-01-18
Start Date Type:
ACTUAL
Primary Completion Date:
2018-08-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-08-08
Completion Date Type:
ACTUAL
First Submit Date:
2017-12-19
First Submit QC Date:
None
Study First Post Date:
2018-01-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-07-29
Last Update Post Date:
2019-07-31
Last Update Post Date Type:
ACTUAL